ZA200805395B - Novel prime-boost combinations of attenuated mycobacterium - Google Patents

Novel prime-boost combinations of attenuated mycobacterium

Info

Publication number
ZA200805395B
ZA200805395B ZA200805395A ZA200805395A ZA200805395B ZA 200805395 B ZA200805395 B ZA 200805395B ZA 200805395 A ZA200805395 A ZA 200805395A ZA 200805395 A ZA200805395 A ZA 200805395A ZA 200805395 B ZA200805395 B ZA 200805395B
Authority
ZA
South Africa
Prior art keywords
attenuated mycobacterium
boost combinations
novel prime
prime
novel
Prior art date
Application number
ZA200805395A
Other languages
English (en)
Inventor
Hone David Michael
Jerald C Sadoff
Original Assignee
Aeras Global Tb Vaccine Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeras Global Tb Vaccine Found filed Critical Aeras Global Tb Vaccine Found
Publication of ZA200805395B publication Critical patent/ZA200805395B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6006—Cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200805395A 2005-12-15 2008-12-15 Novel prime-boost combinations of attenuated mycobacterium ZA200805395B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75034805P 2005-12-15 2005-12-15

Publications (1)

Publication Number Publication Date
ZA200805395B true ZA200805395B (en) 2009-10-28

Family

ID=38228924

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805395A ZA200805395B (en) 2005-12-15 2008-12-15 Novel prime-boost combinations of attenuated mycobacterium

Country Status (6)

Country Link
US (1) US20090304750A1 (pt)
EP (1) EP1962910A4 (pt)
CN (1) CN101432016A (pt)
BR (1) BRPI0620693A2 (pt)
WO (1) WO2007079351A2 (pt)
ZA (1) ZA200805395B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670609B2 (en) * 2007-11-27 2010-03-02 Aeras Global Tb Vaccine Foundation Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
AU2008339980A1 (en) * 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccines for malaria
CN102441162B (zh) * 2010-10-04 2018-07-24 免疫产品美国股份有限公司 结核病的治疗和预防
CN103214582B (zh) * 2013-04-02 2015-04-08 扬州大学 一种针对结核病具有免疫原性的融合蛋白及其应用
JP6554095B2 (ja) 2013-06-25 2019-07-31 アエラス グローバル ティービー ワクチン ファウンデーション 結核組成物及びそれを使用する方法
CN104151433A (zh) * 2014-08-11 2014-11-19 兰州大学 一种结核分枝杆菌融合蛋白及其制备方法和应用
CN109890411A (zh) 2016-06-16 2019-06-14 国际艾滋病疫苗行动组织公司 结核病组合物和治疗或预防结核病的方法
US11091775B2 (en) * 2016-06-22 2021-08-17 Oregon Health And Science University Recombinant cytomegalovirus vectors as vaccines for tuberculosis
EP3697806A4 (en) 2017-10-17 2021-10-27 International AIDS Vaccine Initiative, Inc. TUBERCULOSIS ANTIGEN CASSETTES
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190657B1 (en) * 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
US7045336B1 (en) * 1995-09-06 2006-05-16 The United States Of America As Represented By The Secretary Of The Army Bacterial delivery system
US6210663B1 (en) * 1998-08-20 2001-04-03 The Wistar Institute Of Anatomy And Biology Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
US20040009936A1 (en) * 1999-05-03 2004-01-15 Tang De-Chu C. Vaccine and drug delivery by topical application of vectors and vector extracts
ES2370885T3 (es) * 2004-12-01 2011-12-23 Aeras Global Tuberculosis Vaccine Foundation Electroporación de mycobacterium y sobreexpresión de antígenos en micobacterias.

Also Published As

Publication number Publication date
US20090304750A1 (en) 2009-12-10
WO2007079351A2 (en) 2007-07-12
EP1962910A2 (en) 2008-09-03
WO2007079351A3 (en) 2008-08-14
BRPI0620693A2 (pt) 2016-12-13
EP1962910A4 (en) 2010-03-31
CN101432016A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
ZA200805395B (en) Novel prime-boost combinations of attenuated mycobacterium
AP2108A (en) Novel biphenylsulfonamides
HK1116776A1 (en) Triazolophthalazines as pde2-inhibitors
AU307526S (en) Oven
GB2423693B (en) Improved cookware
GB0505954D0 (en) Novel use
GB0512751D0 (en) New adjuvant
GB2442408B (en) Mycobacterium W as an adjuvant
GB0506001D0 (en) Novel use
EP1846443A4 (en) NEW USE
GB0507672D0 (en) Adjuvant
GB0510207D0 (en) Novel combination
GB2432567B (en) Fall arrest
GB2420545B8 (en) Fall arrest
ZAA200501648S (en) Cooker
GB0521052D0 (en) Novel anti-emetics
GB0511492D0 (en) Cent
GB0511705D0 (en) Cent
GB0514179D0 (en) Downburning stove
ZA200509216B (en) Amadumbe crisps
GB0507516D0 (en) Fall arrest assembly
GB0508694D0 (en) Novel methods
GB0500505D0 (en) Improved cooking apparatus
GB0500666D0 (en) Concelled fire escape
ZAA200501377S (en) Ovens